Epidemiology and antifibrotic therapy of post-COVID-19 interstitial lung disease.

被引：0
|
作者：
Yakovenko, Oleh [1 ]
Khanin, Alexander [2 ]
Griff, Sergej [3 ]
Yakovenko, Tetiana [4 ]
Khodosh, Eduard [5 ]
Dziublyk, Yaroslav [6 ]
机构：
[1] Volyn Reg Clin Hosp, Lutsk, Ukraine
[2] Lesya Ukrainka Volyn Natl Univ, Lutsk, Ukraine
[3] Inst Gewebediagnost Pathol, Berlin, Germany
[4] Allergy & Cough Clin, Lutsk, Ukraine
[5] Kharkiv Natl Med Univ, Kharkiv, Ukraine
[6] NAMS Ukraine, Natl Inst Phthisiol & Pulmonol, Kiev, Ukraine
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA3931
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Benefits of Early Systemic Corticosteroid in Clinical Deterioration of Post-COVID-19 Interstitial Lung Disease
    An, Tai Joon
    Lee, Ye Jin
    Park, Ji Eun
    Lee, Eung Gu
    Kim, Youlim
    Kang, Sung-Yoon
    Joo, Hyonsoo
    Choi, Joon Young
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2022, 85 (04) : 358 - 360
  • [22] Post-COVID-19 interstitial lung disease: A new treatment challenge in rheumatoid arthritis patients
    Morell-Hita, Jose Luis
    Rigual-Bobillo, Juan A.
    Macia-Villa, Cristina C.
    REUMATOLOGIA CLINICA, 2022, 18 (10): : 625 - 626
  • [23] Dynamic shifts in lung cytokine patterns in post-COVID-19 interstitial lung disease patients: a pilot study
    Oatis, Daniela
    Herman, Hildegard
    Balta, Cornel
    Ciceu, Alina
    Simon-Repolski, Erika
    Mihu, Alin Gabriel
    Lepre, Caterina Claudia
    Russo, Marina
    Trotta, Maria Consiglia
    Gravina, Antonietta Gerarda
    D'Amico, Michele
    Hermenean, Anca
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2024, 15
  • [24] THE CLINICAL, FUNCTIONAL, AND RADIOLOGICAL EFFECT OF LONG-TERM USED IMMUNOSUPPRESSIVE THERAPY FOR POST-COVID-19 INTERSTITIAL LUNG DISEASE
    Gul, Sule
    Demirkol, Baris
    Eren, Ramazan
    Baydili, Kursad Nuri
    Elkhatroushi, Burcu Babaoglu
    Ulusan, Serife Nur
    Ilhan, Umut
    Cortuk, Mustafa
    Cetinkaya, Erdogan
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2023, 40 (04)
  • [25] A Potential Role for Antifibrotic Use in Post-COVID-19 Pulmonary Fibrosis
    Ahmad, K.
    Srinivas, S., V
    Century, R. B.
    Abu-Hamda, E.
    Libre, E. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [26] Steroids in Post COVID-19 Interstitial Lung Disease
    Ntiamoah, P.
    Biehl, M.
    Ruesch, V.
    Mehta, A. C.
    Farha, S. Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [27] Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: A randomized, prospective study
    Kerget, Bugra
    Cil, Gizem
    Araz, Omer
    Alper, Fatih
    Akgun, Metin
    MEDICINA CLINICA, 2023, 160 (12): : 525 - 530
  • [28] EXTENSION OF STEROID THERAPY FOR POST-COVID-19 FIBROTIC LUNG SEQUALAE
    TOUMAN, A.
    BULKH, A., I
    AL-QURASH, E., I
    GHALIB, N.
    ALDOBYANY, A.
    CHEST, 2022, 161 (06) : 255A - 255A
  • [29] The importance of obstructive sleep apnea diagnosis in patients with post-COVID-19 interstitial lung disease: Case presentations
    Cetina, Diana-Maria
    Motoc, Nicoleta Stefania
    Campean, Andrada Elena Urda
    Todea, Doina Adina
    JOURNAL OF SLEEP RESEARCH, 2024, 33
  • [30] Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group (vol 39, pg 177, 2022)
    Salvi, S. D.
    Ghorpade, D.
    Dhoori, S.
    Dhar, R.
    Dumra, H.
    Chhajed, P. N.
    LUNG INDIA, 2022, 39 (03) : 310 - 310
12345